Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold?

No abstract is available for this paper.

• Publication year

  2002

• Venue

  International review of neurobiology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0074-7742(02)50083-0PMID 12198818
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of NGF and Neurotrophin‐3 Treatment on Experimental Diabetic Autonomic Neuropathy

  2001cited by this paper
• Efficacy and Safety of Recombinant Human Nerve Growth Factor in Patients With Diabetic Polyneuropathy: A Randomized Controlled Trial

  2000cited by this paper
• Topical treatment with nerve growth factor for neurotrophic keratitis.

  2000cited by this paper
• A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection

  2000cited by this paper
• Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group.

  2000cited by this paper
• Effect of NGF and anti-NGF on neuropathic pain in rats following chronic constriction injury of the sciatic nerve.

  1999cited by this paper
• A vitamin D(3) derivative (CB1093) induces nerve growth factor and prevents neurotrophic deficits in streptozotocin-diabetic rats.

  1999cited by this paper
• A vitamin D3 derivative (CB1093) induces nerve growth factor and prevents neurotrophic deficits in streptozotocin-diabetic rats

  1999cited by this paper
• Clenbuterol stimulates neurotrophic support in streptozotocin‐diabetic rats

  1999cited by this paper
• Peripheral neuropathy in transgenic diabetic mice: restoration of C-fiber function with human recombinant nerve growth factor.

  1998cited by this paper
• Topical treatment with nerve growth factor for corneal neurotrophic ulcers.

  1998cited by this paper
• Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy.

  1998cited by this paper
• Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy

  1998cited by this paper
• Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort

  1997cited by this paper
• The role of endogenous nerve growth factor in human diabetic neuropathy

  1996cited by this paper
• GDNF is an age-specific survival factor for sensory and autonomic neurons.

  1995cited by this paper
• Nerve growth factor alleviates a painful peripheral neuropathy in rats.

  1995cited by this paper
• Variables influencing neuropathic endpoints

  1995cited by this paper
• Human Recombinant Nerve Growth Factor Replaces Deficient Neurotrophic Support in the Diabetic Rat

  1995cited by this paper
• Quantitative Sensory Testing: Methodology, Applications, and Future Directions

  1994cited by this paper
• Reversal by NGF of cytostatic drug-induced reduction of neurite outgrowth in rat dorsal root ganglia in vitro.

  1994cited by this paper
• Nerve growth factor administration protects against experimental diabetic sensory neuropathy.

  1994cited by this paper
• The effect of systemically administered recombinant human nerve growth factor in healthy human subjects

  1994cited by this paper
• GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle.

  1994cited by this paper
• Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor.

  1994cited by this paper
• Low contents of nerve growth factor in serum and submaxillary gland of diabetic mice. A possible etiological element of diabetic neuropathy.

  1994cited by this paper
• Deficits in sciatic nerve neuropeptide content coincide with a reduction in target tissue nerve growth factor messenger RNA in streptozotocin-diabetic rats: effects of insulin treatment.

  1994cited by this paper
• Diabetic neuropathy, nerve growth factor and other neurotrophic factors.

  1994cited by this paper
• Axonal transport of endogenous nerve growth factor (NGF) and NGF receptor in experimental diabetic neuropathy.

  1994cited by this paper
• Nerve growth factor prevents neurotoxic effects of cisplatin, vincristine and taxol, on adult rat sympathetic ganglion explants in vitro.

  1994cited by this paper
• Nerve growth factor prevents experimental cisplatin neuropathy

  1992cited by this paper
• trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3.

  1991cited by this paper
• The trk proto-oncogene encodes a receptor for nerve growth factor.

  1991cited by this paper
• The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3.

  1991cited by this paper
• Nerve growth factor prevents toxic neuropathy in mice

  1991cited by this paper
• Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: A possible role for NGF in the pathogenesis of diabetic neuropathy

  1990cited by this paper
• A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man

  1988cited by this paper
• The nerve growth factor: thirty‐five years later.

  1987cited by this paper
• Nerve growth factor attenuates neurotoxic effects of taxol on spinal cord-ganglion explants from fetal mice.

  1982cited by this paper
• Retrograde Axonal Transport of Transmitter Enzymes, Fucose-Labeled Protein, and Nerve Growth Factor in Streptozotocin-Diabetic Rats

  1981cited by this paper
• Destruction of the sympathetic nervous system in neonatal rats and hamsters by vinblastine: prevention by concomitant administration of nerve growth factor.

  1978cited by this paper
• A NERVE GROWTH-STIMULATING FACTOR ISOLATED FROM SARCOM AS 37 AND 180.

  1954cited by this paper

• Designing Next-Generation Biomaterials to Enhance Peripheral Nerve Repair and Reconstruction.

  2025cites this paper
• A painless nerve growth factor variant uncouples nociceptive and neurotrophic TrkA signaling

  2025cites this paper
• Nerve Growth Factor in Diabetes Mellitus: Pathophysiological Mechanisms, Biomarkers and Therapeutic Opportunities

  2025cites this paper
• Assessment and Rehabilitation in Cervical Radiculopathy—Efficacy of Structured Program with or Without Neurotrophic Agents

  2025cites this paper
• Osteoblast-derived Nerve Growth Factor is Required for Skeletal Adaptation to Mechanical Load and the Osteoanabolic Effect of Gambogic Amide in Mice

  2025cites this paper
• Selection of sciatic nerve injury models: implications for pathogenesis and treatment

  2025cites this paper
• Recent advances in the role of neuroregulation in skin wound healing

  2025cites this paper
• Effects of exogenous ghrelin treatment on oxidative stress, inflammation and histological parameters in a fat-fed streptozotocin rat model

  2024influential citation
• Small fibre integrity and axonal pathology in the rat model of experimental autoimmune neuritis

  2024cites this paper
• The History of Nerve Growth Factor: From Molecule to Drug

  2024cites this paper
• 1953-2023. Seventy Years of the Nerve Growth Factor: A Potential Novel Treatment in Neurological Diseases?

  2024cites this paper
• Effect of Carnosine Supplementation as Add-On Therapy With Vitamin B Complex in People With Type 2 Diabetes and Diabetic Neuropathy: A Randomized Controlled Study.

  2024cites this paper
• Neurotrophin peptidomimetics for the treatment of neurodegenerative diseases.

  2024cites this paper
• The Physiologic Basis of Molecular Therapeutics for Peripheral Nerve Injury: A Primer

  2024cites this paper
• Navigating Preclinical Models and Medications for Peripheral Neuropathy: A Review

  2024cites this paper
• Novel drugs affecting diabetic peripheral neuropathy

  2024cites this paper
• RETRACTED ARTICLE: Exploring the Therapeutic Effect of Neurotrophins and Neuropeptides in Neurodegenerative Diseases: at a Glance

  2023cites this paper
• Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Novel Recombination Human Nerve Growth Factor in Healthy Chinese Subjects

  2023cites this paper
• Genetically Engineered Artificial Microvesicles Carrying Nerve Growth Factor Restrains the Progression of Autoimmune Encephalomyelitis in an Experimental Mouse Model

  2023cites this paper
• Reversal of neurological deficits by painless nerve growth factor in a mouse model of Rett syndrome

  2023cites this paper
• A multimodal, comprehensive characterization of a cutaneous wound model in healthy volunteers

  2023cites this paper
• Pharmacokinetics and toxicology studies of new neuronal growth factor

  2023cites this paper
• Biomechanical microenvironmental stimulating effect of pulsed electromagnetic field on the regeneration of crush injured rat sciatic nerve

  2023cites this paper
• Snake venom nerve growth factor-inspired designing of novel peptide therapeutics for the prevention of paraquat-induced apoptosis, neurodegeneration, and alteration of metabolic pathway genes in the rat pheochromocytoma PC-12 cell.

  2023cites this paper
• A Vicious NGF-p75NTR Positive Feedback Loop Exacerbates the Toxic Effects of Oxidative Damage in the Human Retinal Epithelial Cell Line ARPE-19

  2023cites this paper
• Autophagy and anti-inflammation ameliorate diabetic neuropathy with Rilmenidine

  2023cites this paper
• Lipid Nanoparticle Delivery of Chemically Modified NGFR100W mRNA Alleviates Peripheral Neuropathy

  2022cites this paper
• Curcumin Ameliorates the Experimental Diabetic Peripheral Neuropathy through Promotion of NGF Expression in Rats

  2022cites this paper
• Diabetic Corneal Neuropathy: Pathogenic Mechanisms and Therapeutic Strategies

  2022cites this paper
• The effects of painless nerve growth factor on human microglia polarization

  2022cites this paper
• Nerve growth factor and burn wound healing: Update of molecular interactions with skin cells.

  2022cites this paper
• Long-Term Intranasal Nerve Growth Factor Treatment Favors Neuron Formation in de novo Brain Tissue

  2022influential citation
• Basic Mechanisms of Pain in Osteoarthritis: Experimental Observations and New Perspectives.

  2021cites this paper
• An iPSC model of hereditary sensory neuropathy-1 reveals L-serine-responsive deficits in neuronal ganglioside composition and axoglial interactions

  2021cites this paper
• Nerve Growth Factor as an Ocular Therapy: Applications, Challenges, and Future Directions

  2021cites this paper
• Association of Diabetic Peripheral Neuropathy with Vitamin D Levels Depends on Vitamin D Status

  2021cites this paper
• Advances About Immunoinflammatory Pathogenesis and Treatment in Diabetic Peripheral Neuropathy

  2021cites this paper
• Intranasal Delivery of Nerve Growth Factor in Neurodegenerative Diseases and Neurotrauma

  2021influential citation
• Topical delivery of nerve growth factor for treatment of ocular and brain disorders

  2021cites this paper
• Nerve Growth Factor Biodelivery: A Limiting Step in Moving Toward Extensive Clinical Application?

  2021cites this paper
• A ketogenic diet reduces mechanical allodynia and improves epidermal innervation in diabetic mice.

  2021cites this paper
• Long-term effects of muscle-derived stem cell therapy on the regeneration of the urethra of female rats

  2021cites this paper
• Growth factors-based therapeutic strategies and their underlying signaling mechanisms for peripheral nerve regeneration

  2020cites this paper
• The TrkA agonist gambogic amide augments skeletal adaptation to mechanical loading through actions on sensory nerves and osteoblasts

  2020cites this paper
• Therapeutic repair for spinal cord injury: combinatory approaches to address a multifaceted problem

  2020cites this paper
• Targeting neurotrophic factors: Novel approaches to musculoskeletal pain.

  2020cites this paper
• Discovery of Novel Analgesic Agents Targeting Neuropathic Pain: Computer-Aided Drug Design

  2020cites this paper
• Evolving concepts on the role of dyslipidemia, bioenergetics, and inflammation in the pathogenesis and treatment of diabetic peripheral neuropathy

  2020cites this paper
• New targets and therapeutics for neuroprotection, remyelination and repair in multiple sclerosis

  2020cites this paper
• Vincristine- and bortezomib-induced neuropathies - from bedside to bench and back.

  2020cites this paper
• Biomimetic Approaches for Separated Regeneration of Sensory and Motor Fibers in Amputee People: Necessary Conditions for Functional Integration of Sensory–Motor Prostheses With the Peripheral Nerves

  2020influential citation
• Diabetic Peripheral Neuropathy: Diagnosis and Treatment.

  2020cites this paper
• Nerve Growth Factor Signaling and Its Contribution to Pain

  2020cites this paper
• The delicate balance between neurotoxicity and neuroprotection in the context of HIV‐1 infection

  2020cites this paper
• The effect of rat nerve growth factor combined with vitamin B on peripheral neuropathy in multiple myeloma patients

  2020cites this paper
• Diabetic neuropathy and neuropathic pain: a (con)fusion of pathogenic mechanisms?

  2020cites this paper
• Regenerative Therapies for Acquired Axonal Neuropathies

  2020cites this paper
• Serum Nerve Growth Factor in the Occurrence of Peripheral Neuropathy in Rheumatoid Arthritis Patients

  2020cites this paper
• Duloxetine, a Balanced Serotonin-Norepinephrine Reuptake Inhibitor, Improves Painful Chemotherapy-Induced Peripheral Neuropathy by Inhibiting Activation of p38 MAPK and NF-κB

  2019cites this paper
• Enlarged Areas of Pain and Pressure Hypersensitivityby Spatially Distributed Intramuscular Injections ofLow-Dose Nerve Growth Factor.

  2019cites this paper
• Painless Nerve Growth Factor: A TrkA biased agonist mediating a broad neuroprotection via its actions on microglia cells

  2019cites this paper
• Biodelivery of nerve growth factor and gold nanoparticles encapsulated in chitosan nanoparticles for schwann-like cells differentiation of human adipose-derived stem cells.

  2019cites this paper
• The Effects of Traditional Chinese Medicine Herb Tangluoning in Diabetic Peripheral Neuropathy

  2019cites this paper
• An update on the diagnosis and treatment of diabetic somatic and autonomic neuropathy

  2019cites this paper
• ProNGF and Neurodegeneration in Alzheimer’s Disease

  2019cites this paper
• Nerve Growth Factor Improves the Outcome of Type 2 Diabetes–Induced Hypotestosteronemia and Erectile Dysfunction

  2019cites this paper
• The NGFR100W Mutation Specifically Impairs Nociception without Affecting Cognitive Performance in a Mouse Model of Hereditary Sensory and Autonomic Neuropathy Type V

  2019cites this paper
• A Missense Point Mutation in Nerve Growth Factor (NGFR100W) Results in Selective Peripheral Sensory Neuropathy

  2019cites this paper
• Improvement of cognitive functions by oral intake of Hericium erinaceus.

  2019cites this paper
• Enhancing the expression of neurotrophic factors in epidermal neural crest stem cells by valproic acid: A potential candidate for combinatorial treatment.

  2019cites this paper
• Efficacy of autologous bone marrow mononuclear cell transplantation therapy in patients with refractory diabetic peripheral neuropathy

  2019cites this paper
• Nerve growth factor antibody for the treatment of osteoarthritis pain and chronic low-back pain: mechanism of action in the context of efficacy and safety

  2019influential citation
• Nerve growth factor gene therapy improves bone marrow sensory innervation and nociceptor-mediated stem cell release in a mouse model of type 1 diabetes with limb ischaemia

  2019cites this paper
• Investigation of the Development of Hypersensitivity and Hyperalgesia After Repeated Application of Platelet-Rich Plasma in Rats: An Experimental Study.

  2019cites this paper
• Panax ginseng (Korea Red Ginseng) repairs diabetic sensorineural damage through promotion of the nerve growth factor pathway in diabetic zebrafish

  2018cites this paper
• Swedish Nerve Growth Factor Mutation (NGFR100W) Defines a Role for TrkA and p75NTR in Nociception

  2018cites this paper
• Effects of Monoclonal Antibodies against Nerve Growth Factor on Healthy Bone and Joint Tissues in Mice, Rats, and Monkeys: Histopathologic, Biomarker, and Microcomputed Tomographic Assessments

  2018cites this paper
• Nerve Growth Factor: Early Studies and Recent Clinical Trials

  2018cites this paper
• Anti-nerve growth factor monoclonal antibodies for the control of pain in dogs and cats

  2018cites this paper
• Corneal Neuropathy: An Underrated Manifestation of Diabetes Mellitus.

  2018cites this paper
• Molecular and immunohistochemical analysis of the urethra of female rats after induced trauma and intravenous therapy with muscle derived stem cells

  2018cites this paper
• Neurotrophic Factors: An Overview.

  2018cites this paper
• 4231 Comprision of the effect of aerobic and weight resistance training protocols on balance and neuron growth factor(NGF) on the Neuropathy– Diabetic

  2018cites this paper
• Impact of Exogenous Neurotropic Factor Administration on Occurrence and Severity of Paclitaxel-Induce Neuropathy in Breast Cancer Patients. An open label Pilot Study.

  2018cites this paper
• Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets

  2018cites this paper
• NGF and PI3K/Akt signaling participate in the ventral motor neuronal protection of curcumin in sciatic nerve injury rat models.

  2018cites this paper
• Diagnosing Diabetic Neuropathy: Something Old, Something New

  2018cites this paper
• Distinct TrkA and Ret modulated negative and positive neuropathic behaviors in a mouse model of resiniferatoxin‐induced small fiber neuropathy

  2018cites this paper
• Synergy and convergence of pathways controlling functional regeneration in the spinal cord

  2018cites this paper
• Gene Expression Profiling Identifies Downregulation of the Neurotrophin-MAPK Signaling Pathway in Female Diabetic Peripheral Neuropathy Patients

  2017cites this paper
• Ecto-Phosphorylation and Regeneration of the Adult Central Nervous System

  2017cites this paper
• Preconditioning of adipose tissue-derived mesenchymal stem cells with deferoxamine increases the production of pro-angiogenic, neuroprotective and anti-inflammatory factors: Potential application in the treatment of diabetic neuropathy

  2017cites this paper
• Clinical tests of neurotrophic factors for human neurodegenerative diseases, part 1: Where have we been and what have we learned?

  2017cites this paper
• Nerve growth factor derivative NGF61/100 promotes outgrowth of primary sensory neurons with reduced signs of nociceptive sensitization

  2017influential citation
• Tethering Growth Factors to Collagen Surfaces Using Copper-Free Click Chemistry: Surface Characterization and in Vitro Biological Response.

  2017cites this paper
• Depletion of nerve growth factor in chemotherapy-induced peripheral neuropathy associated with hematologic malignancies

  2017cites this paper
• Targeting the Nerve Growth Factor (NGF) Pathway in Drug Discovery. Potential Applications to New Therapies for Chronic Pain.

  2017cites this paper
• A Comparison of Neuropathic Pain in HIV Disease and Diabetes Mellitus

  2017cites this paper
• Quercetin promotes motor and sensory function recovery following sciatic nerve-crush injury in C57BL/6J mice.

  2017cites this paper
• Development of novel HDL-mimicking α-tocopherol-coated nanoparticles to encapsulate nerve growth factor and evaluation of biodistribution.

  2016cites this paper